On May 26, Insilico Medicine (03696.HK) declined 5.04% in regular trading, trading at 49.18 HKD/share, with trading volume of approximately 55.53 million HKD.
Within the Life Sciences Tools & Services sector where Insilico Medicine belongs, individual stock performance was mixed. Among individual stocks, WuXi Biologics up 6.48%, Genscript Biotech up 1.39%, WuXi AppTec down 0.31%, WuXi XDC down 0.35%, XtalPi down 1.38%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)